Aiosyn

About Aiosyn

Aiosyn is a Dutch healthtech company delivering AI-powered precision pathology solutions to enhance diagnosis and accelerate research in breast cancer and chronic kidney disease. Our algorithms integrate with existing digital pathology software and can be deployed via cloud-based or on-premise installations, ensuring adaptability to diverse laboratory environments.

We support digital pathology labs with automated slide quality control (QC) and offer the first IVDR-certified AI solution for mitotic figure counting, improving consistency and efficiency in breast cancer grading. Our NephroPath platform enables quantitative kidney biomarker analysis for CROs and biopharma, helping streamline and scale (pre-)clinical drug development.

Keywords

• Anatomical Pathology
• Artificial Intelligence
• Biomarker Development
• Cancer
• Cancer Diagnostics
• Cancer Research
• Ckd Research
• Clinical Diagnostics
• Clinical Pathology
• Companion Diagnostics
• Computational Pathology
• Computer Vision
• Computer-Aided Diagnostics
• Data Science
• Deep Learning
• Deep Learning Image Analysis
• Diagnostics
• Digital Pathology
• Image Analysis
• Machine Learning
• Medical Device
• Medical Imaging
• Medical Research
• Neural Networks
• Pathology
• Pharma Services
• Precision Medicine
• Quantitative Digital Pathology
• Research And Development

Address

• Headquarters

  Toernooiveld 3006525EC NijmegenGelderland, Netherlands

Team by function

Based on 12 public job profiles as of 3 September 2026.

• Engineering / Software Development3
• Executive / C-Suite2
• Legal / Compliance2
• Research / R&D2
• Finance / Accounting1
• Founder / Owner1
• Marketing1